Illumina Collaborates With 54gene in the Creation of a World-Class Genomics Facility in Nigeria

CAMBRIDGE, England–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced a collaboration with 54gene, a health technology company whose mission is to advance precision medicine capabilities in Africa through research, advanced molecular diagnostics and clinical programs. The partnership will support the establishment of a new genetics facility in Lagos, Nigeria, equipped with a suite of Illumina’s cutting-edge sequencing and high-density microarray technology platforms, which will gen